Yumi Yamashita

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Accelerated tumor growth in mice deficient in DNAM-1 receptor

Akiko Iguchi‐Manaka, Hirayasu Kai, Yumi Yamashita et al. · The Journal of Experimental Medicine · 2008 · 277 citations · Full text

Array-based genomic resequencing of human leukemia

Yumi Yamashita, Jin Yuan, Isao Suetake et al. · Oncogene · 2010 · 248 citations

Dna Sequencing, Next-generation Sequencing, Genetics +4

Molecular Cloning of a Novel Murine Cell-surface Glycoprotein Homologous to Killer Cell Inhibitory Receptors

Keiko Hayami, Daisuke Fukuta, Yasuhiro Nishikawa et al. · Journal of Biological Chemistry · 1997 · 167 citations · Full text

IgE-dependent Activation of Sphingosine Kinases 1 and 2 and Secretion of Sphingosine 1-Phosphate Requires Fyn Kinase and Contributes to Mast Cell Responses

Ana Olivera, Nicole Urtz, Kiyomi Mizugishi et al. · Journal of Biological Chemistry · 2005 · 137 citations · Full text